Stay updated on NasoVAX in Early COVID-19 Clinical Trial
Sign up to get notified when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.
Latest updates to the NasoVAX in Early COVID-19 Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Terminated Enrollment for NCT04442230, with the study status updated and enrollment closed.SummaryDifference0.5%
- Check12 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a prominent operating-status notice and version bump to v3.2.0; removed the previous v3.1.0 version reference.SummaryDifference4%
- Check40 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.5%
- Check55 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top control has been removed.SummaryDifference0.2%
- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and post-COVID conditions. However, several location-related terms and disease attributes have been removed.SummaryDifference4%
Stay in the know with updates to NasoVAX in Early COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.